questions for the clever ones here. I'm new to biotechs, so excuse my ignorance.
what type of money values are we looking at for licensing?
did you get a feel that the CellPryme-M technique required specialty (read expensive) equipment to perform(which may also be monetisable) or can it be performed by any lab involved in CAR-T with "standard" CAR-T tech.
DZ
questions for the clever ones here. I'm new to biotechs, so...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.001(2.13%) |
Mkt cap ! $37.04M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.9¢ | 4.6¢ | $46.00K | 956.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 86350 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 170704 | 4 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.8¢ |
Change
-0.001 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 5.0¢ | 4.7¢ | 566571 | ||
| Last updated 13.35pm 07/06/2024 ? | |||||
| PTX (ASX) Chart |